首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice.
【24h】

Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice.

机译:一般实践中,TRUS在直肠癌的治疗分期中的可行性和准确性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIMS: Transrectal ultrasonography (TRUS) is the diagnostic tool of choice for local staging of rectal carcinoma. The accuracy in determining of tumour infiltration depth has been reported to reach 95% (on average, 85%). The aim of the study was to analyse the diagnostic accuracy of the TRUS in the clinical routine. PATIENTS AND METHODS: From 01/01/2000 to 12/31/2003, all patients with rectal carcinoma were enrolled in a prospective multicenter observational study. In case of complete findings of pre-operative TRUS and post-operative histological investigation of the surgical specimen on the tumour infiltration depth, overall accuracy of TRUS was determined. RESULTS: Overall, 13,610 patients with rectal carcinoma were enrolled in the study. Five thousand and fifty-six subjects (37%) underwent TRUS. In 3,501 patients, TRUS finding (uT-stage) could be compared with the result of the definitive histologic investigation (pT-stage). The accuracy of TRUS in all T-stages was 65.8%. The highest sensitivity was achieved in the T3-stage (74.9%), while in T2, T1, and T4, it was 59.6, 59.0 and 31.1%, respectively. In discriminating tumour growth limited to the rectal wall vs that through the rectal wall into the neighboring tissue, TRUS-associated accuracy was 76.5%. There were no differences between various tumour locations above the anocutaneous line. CONCLUSIONS: Diagnostic accuracy of TRUS in determining depth of tumour infiltration within or through the rectum wall in the routinuous diagnostic of rectal carcinoma does not reach the excellent published study results. A considerable improvement of the qualitative outcome in using this specific diagnostic tool appears to be recommendable to utilize its advantages such as high accuracy, efficacy, and practicability in the diagnostic process and deriving consequences for a possible neoadjuvant treatment as well as optimal planning of the surgical approach.
机译:目的:经直肠超声检查(TRUS)是直肠癌局部分期的首选诊断工具。据报道,确定肿瘤浸润深度的准确性达到了95%(平均为85%)。该研究的目的是分析TRUS在临床常规中的诊断准确性。患者与方法:从2000年1月1日至2003年12月31日,所有直肠癌患者均参加了一项前瞻性多中心观察性研究。如果在手术前完整发现TRUS以及对手术标本进行肿瘤浸润深度的手术后组织学检查,则可确定TRUS的总体准确性。结果:总共纳入了13,610例直肠癌患者。 556名受试者(37%)接受了TRUS。在3,501位患者中,可以将TRUS的发现(uT期)与确定的组织学检查结果(pT期)进行比较。 TRUS在所有T阶段的准确性为65.8%。在T3阶段获得了最高的灵敏度(74.9%),而在T2,T1和T4中分别达到了59.6、59.0和31.1%。在区分局限于直肠壁的肿瘤生长与通过直肠壁进入邻近组织的肿瘤生长之间,与TRUS相关的准确性为76.5%。在经皮线以上的各个肿瘤位置之间没有差异。结论:在直肠癌的常规诊断中,TRUS在确定直肠壁内或穿过直肠壁的浸润深度方面的诊断准确性未达到出色的已发表研究结果。使用这种特定诊断工具的定性结果的显着改善似乎是可取的,以利用其优势,例如在诊断过程中具有较高的准确性,功效和实用性,并为可能的新辅助治疗以及对手术的最佳规划带来了后果方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号